Literature DB >> 14557474

Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.

Rémi Rabasa-Lhoret1, Jean-Philippe Bastard, Véronique Jan, Pierre-Henri Ducluzeau, Fabrizio Andreelli, Fitsum Guebre, Joëlle Bruzeau, Corinne Louche-Pellissier, Christine MaItrepierre, Jocelyne Peyrat, Jérôme Chagné, Hubert Vidal, Martine Laville.   

Abstract

Fasting-based index estimates of insulin sensitivity were compared with euglycemic hyperinsulinemic clamp (IS clamp) measurements in 148 subjects: normal controls (n = 46), and obese (n = 12), polycystic ovary syndrome (n = 16), first-degree relatives of type 2 diabetic (n = 17), impaired glucose tolerance (n = 28), and type 2 diabetic (n = 29) patients. The fasting-based indexes tested included log homeostasis model assessment (HOMA), the quantitative insulin sensitivity check index (QUICKI), the revised QUICKI, and a new revised QUICKI using fasting plasma glycerol. In the population studied, at 40 mU/m(2).min (n = 30) revised QUICKI (r = 0.86; P < 0.0001) and QUICKI-glycerol (r = 0.87; P < 0.0001) gave higher correlations with the IS clamp than QUICKI and log HOMA (r = 0.78 and r = -0.78; P < 0.001). For subjects tested at 75 mU/m(2).min (n = 118), comparable correlations were found for all indexes (r > 0.80; P < 0.0001). When studied in subgroups, revised QUICKI and QUICKI-glycerol give significantly higher correlations with the IS clamp than other indexes for lean control subjects studied at 40mU/m(2).min and impaired glucose tolerance subjects. We confirmed, in a large patient population with a wide range of insulin sensitivities, that no single test is superior in all groups of patients. However, QUICKI and revised QUICKI are good indexes that offer correlations similar to or higher than values obtained with log HOMA. Such indexes are simple tools to estimate insulin sensitivity appropriate for epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557474     DOI: 10.1210/jc.2002-030316

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

2.  Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus.

Authors:  Christine G Lee; Edward J Boyko; Elsa S Strotmeyer; Cora E Lewis; Peggy Mannen Cawthon; Andrew R Hoffman; Susan A Everson-Rose; Elizabeth Barrett-Connor; Eric S Orwoll
Journal:  J Am Geriatr Soc       Date:  2011-06-30       Impact factor: 5.562

3.  Methods for quantifying adipose tissue insulin resistance in overweight/obese humans.

Authors:  K W Ter Horst; K A van Galen; P W Gilijamse; A V Hartstra; P F de Groot; F M van der Valk; M T Ackermans; M Nieuwdorp; J A Romijn; M J Serlie
Journal:  Int J Obes (Lond)       Date:  2017-05-03       Impact factor: 5.095

4.  Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention.

Authors:  Iain A Brownlee; Carmel Moore; Mark Chatfield; David P Richardson; Peter Ashby; Sharron A Kuznesof; Susan A Jebb; Chris J Seal
Journal:  Br J Nutr       Date:  2010-03-23       Impact factor: 3.718

5.  Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.

Authors:  Ursula Hanusch-Enserer; Mohammed A Ghatei; Edmund Cauza; Steven R Bloom; Rudolf Prager; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Role of insulin, insulin sensitivity, and abomasal functions monitors in evaluation of the therapeutic regimen in ketotic dairy cattle using combination therapy with referring to milk yield rates.

Authors:  Enas Elmeligy; Shin Oikawa; Sabry A Mousa; Sara A Bayoumi; Ahmed Hafez; Ragab H Mohamed; Al-Lethie A Al-Lethie; Dalia Hassan; Arafat Khalphallah
Journal:  Open Vet J       Date:  2021-04-30

7.  Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial.

Authors:  Susan A Jebb; Julie A Lovegrove; Bruce A Griffin; Gary S Frost; Carmel S Moore; Mark D Chatfield; Les J Bluck; Christine M Williams; Thomas Ab Sanders
Journal:  Am J Clin Nutr       Date:  2010-08-25       Impact factor: 7.045

8.  Infliximab improves vascular stiffness in patients with rheumatoid arthritis.

Authors:  M Wong; S P Oakley; L Young; B Y Jiang; A Wierzbicki; G Panayi; P Chowienczyk; B Kirkham
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

9.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.

Authors:  Lisa Mosconi; Valentina Berti; Crystal Quinn; Pauline McHugh; Gabriella Petrongolo; Isabella Varsavsky; Ricardo S Osorio; Alberto Pupi; Shankar Vallabhajosula; Richard S Isaacson; Mony J de Leon; Roberta Diaz Brinton
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

Review 10.  A systematic review and meta-analysis of the association between depression and insulin resistance.

Authors:  Carol Kan; Naomi Silva; Sherita Hill Golden; Ulla Rajala; Markku Timonen; Daniel Stahl; Khalida Ismail
Journal:  Diabetes Care       Date:  2013-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.